PDA Letter
Home / PDA Letter / Aseptic Processing & Sterilization

Aseptic Processing & Sterilization

Three Technologies Boosting Sterility Assurance in Life-Science Aseptic Processes

PDA Staff Author: David Jaworski, MBA

Optimizing Cleanroom Disinfection

Karan Khairnar, MS, Ecolab Life Sciences

Preventing Condensation in Cleanrooms

Tony Cundell, PhD, Microbiological Consulting, LLC

Setting the Standard

Katharina Schlereth, Labor LS

HEPA Filter Management—Industry Survey Results

Brandon L. Stiff, CSSBB, Merck & Co.

Managing Ready-to-Use (RTU) Containers in Aseptic Production Facilities

Alliance for RTU and IMA Life

Three Sterility-Enhancing Technologies for Aseptic Life-Science Processes

PDA Staff Author: David Jaworski, MBA

EU GMP Annex 1. Implementation of Contamination Control Strategy

Anne Moreau, GSK Vacccines

Equivalence Testing of BFPCs in Grade A Environments

Mads Lichtenberg, PhD, Fujifilm Biotechnologies, et. al.

Harnessing HACCP for Aseptic Filling

Abu Sadat Muhammod Saiyem, Square Pharmacuetical Limited

Get Ecstatic for Aseptic

David Keen, Ecolab Life Sciences

What is the Best Way to Control Contamination on the Hands?

PDA Staff Author: David Jaworski, MBA

Challenges in Sterilizing Indirect Product-Contact Surfaces

Cecilia Pierobon, STERIS

Five Important Insights from the PDA Europe Annex 1 Event

Patrick Nieuwenhuizen, PharmaLex

GMP Annex 1 Implementation

Andrea Salmaso, Stevanato Group

The 2025 Kilmer Conference

Michael Sadowski, Sterilexcellence

Modern Microbial Methods Supporting a Contamination Control Strategy

Allison Scott, Particle Measuring Systems, et al.

Q&A on the Revised PDA Technical Report No. 22

Subrata Chakraborty, PhD, INOVR , Vanessa Figueroa, VVF Science , and Marcia C. Baroni, MBA, Emergent BioSolutions Inc

New Training Course – Manage your Aseptic Filling Line

Julian Petersen, groninger & co. gmbh

How Best to Act Locally to Manage Globally in Aseptic Processing

PDA

A Holistic Approach to CCI is a Deterministic Approach

Oliver Stauffer, PTI

Pathway to a Contamination Control Strategy

Londa Ritchey and Patrick Nieuwenhuizen, PharmaLex

Aseptic Transfers to Grade A

Julian Petersen, groninger & co. gmbh and Richard Denk, SKAN AG

Points to Consider on Aseptic Filling Technologies Nearing Completion

Rebecca Brewer, Quality Executive Partners

Intrinsic Sterile Connection Devices

William Peterson, Merck

Legacy Filling Lines Evolve

Ahmed Elsaid, Emergent Biosolution and Ajay Pazhayattil, PhD, cGMP World

The Key to Compliance with Annex 1 and Risk Based Regulations

Noelle Clifford, PharmaLex, PharmaLex

A View on the Revised Annex 1

Antonio Burazer, Takeda , Alexander Artau, Sanofi , Elisabeth Wagner,  CSL Behring , and Joseph Straub, Merck

Biosafety Guidelines for Handling Microorganisms in Microbiology Laboratories

Tony Cundell, PhD, Microbiological Consulting, LLC

Microbial Control During Low-Risk Aseptic Processing

PDA Staff Author: David Jaworski, MBA